38 articles for J Kehler
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
13
Synthesis and SAR study of novel tricyclic pyrazoles as potent phosphodiesterase 10A inhibitors.

University of Sassari
35
Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT6 and dopamine D2 receptor ligands.

University of Copenhagen
10
Synthesis and biological evaluation of 4-(aminomethyl)-1-hydroxypyrazole analogues of muscimol as¿-aminobutyric acid(a) receptor agonists.

University of Copenhagen
20
4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships.

University of Copenhagen
20
Novel 7-phenylsulfanyl-1,2,3,4,10,10a-hexahydro-pyrazino[1,2-a]indoles as dual serotonin 5-HT2C and 5-HT6 receptor ligands.

University of Copenhagen
48
Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors.

H. Lundbeck
63
Identification of a new series of non-peptidic NK3 receptor antagonists.

H. Lundbeck
20
Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors.

University of Sassari
27
Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1.

University of Copenhagen
12
Novel 5-substituted 1-pyrazolol analogues of ibotenic acid: synthesis and pharmacology at glutamate receptors.

The Danish University of Pharmaceutical Sciences
17
Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transporters.

University of Oslo
11
Bioisosteric determinants for subtype selectivity of ligands for heteromeric GABA(A) receptors.

The Royal Danish School of Pharmacy
9
Discovery of 2-(Imidazo[1,2- b]pyridazin-2-yl)acetic Acid as a New Class of Ligands Selective for the γ-Hydroxybutyric Acid (GHB) High-Affinity Binding Sites.

University of Copenhagen
27
N-Methylanilide and N-methylbenzamide derivatives as phosphodiesterase 10A (PDE10A) inhibitors.

H. Lundbeck
15
Spirocyclic compounds

C4 Therapeutics
228
Compositions and methods for treating CNS disorders

Sage Therapeutics
4
Substituted piperidine compounds and their use

Eisai R&D Management
24
SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. Hoffmann-La Roche
106
Substituted pyridines as TYK2 inhibitors

Esker Therapeutics
30
Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2

Effector Therapeutics
378
Piperidines as menin inhibitors

University of Michigan
161
Inhibitors of cyclin-dependent kinases

Kinnate Biopharma
271
Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors

Vanderbilt University
94
Inhibitors of TRPC6

Boehringer Ingelheim International
352
HIV protease inhibitors

Gilead Sciences
4
Pyrrolopyrimidine comprising cyclopentyl substituent

Centaurus Biopharma
121
Tricyclic compounds as inhibitors of mutant IDH enzymes

Merck Sharp & Dohme
3
BACE inhibitors

Eli Lilly
22
Treatment of inflammatory bowel disease

Allergan
8
Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same

Chang Gung University
5
Tampering with cell division by using small-molecule inhibitors of CDK-CKS protein interactions.

Universit�� Pierre Et Marie Curie
24
Targeting GSK3 from Ustilago maydis: Type-II Kinase Inhibitors as Potential Antifungals.

Technische UniversitÄT Dortmund
11
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

TBA
16
[3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.

Eli Lilly
1
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

Hoechst Marion Roussel
6
[3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.

University of Pennsylvania